The cost, which is confidential & was negotiated for a maximum of 300 huge number of doses, is a little less than the $19.50 a shot the United States agreed to pay for a first shipment of 100 million doses of the same vaccine, in series with what Reuters claimed in November.
The EU document dated Nov. eighteen was circulated internally right after the EU announced the supply package of its with Pfizer and the German partner BioNTech of its on Nov. 11.
The EU drug regulator is actually anticipated to determine on Monday on acceptance for the Pfizer vaccine following the shot was authorised in a few countries, including Britain and the United States.
On Thursday Belgian declare secretary for the spending budget Eva De Bleeker published on Twitter a dining room table with costs Belgium would spend pharmaceutical companies for the COVID-19 vaccines of theirs. She retracted the post shortly after posting.
In that dining room table the Pfizer vaccine was indicated as costing Belgium 12 euros ($14.6) per dose, leading many to believe that has been the total cost agreed with the EU.
Various other vaccines in the table were additionally shown with prices lower than rates disclosed by EU solutions.
“There is , obviously , a total price and a price after delivery,” an EU official required in talks with vaccine creators told Reuters when made to clarify the difference between the Belgian and EU prices.
A spokesman for De Bleeker declined to comment on Monday, citing confidentiality requirements, but pointed to what De Bleeker told the Belgian parliament previous week. In that public hearing, De Beeker stated Belgium’s budgeted costs were still partial.
Underneath EU advance purchase deals for COVID-19 vaccines, the bloc believes initial payments with businesses to secure doses before they are approved. After approvals, EU governments can pay the remainder to get reserved doses.
The EU hasn’t revealed the initial payment agreed with Pfizer.
Nevertheless, it stated in October which it paid about 1 billion euros inside downpayments to AstraZeneca, Sanofi and Johnson & Johnson for their shots, with an additional 1.45 billion euros budgeted for initial payments to Pfizer-BioNTech, Curevac and Moderna.
It’s since agreed supply deals with all 6 corporations and is negotiating a seventh agreement with Novavax.